Related references
Note: Only part of the references are listed.Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Melanie Schoof et al.
ACTA NEUROPATHOLOGICA (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features
Emily A. Sloan et al.
ACTA NEUROPATHOLOGICA (2020)
The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
A. Tauziede-Espariat et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
A. Tauziede-Espariat et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2017)
Share Paper
